Cargando…

Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma

Glioblastoma is a devastating malignant brain tumor with a poor prognosis despite standard therapy. Podoplanin (PDPN), a type I transmembrane mucin-like glycoprotein that is overexpressed in various cancers, is a potential therapeutic target for the treatment of glioblastoma. We previously reported...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chalise, Lushun, Kato, Akira, Ohno, Masasuke, Maeda, Sachi, Yamamichi, Akane, Kuramitsu, Shunichiro, Shiina, Satoshi, Takahashi, Hiromi, Ozone, Sachiko, Yamaguchi, Junya, Kato, Yukinari, Rockenbach, Yumi, Natsume, Atsushi, Todo, Tomoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364057/ https://www.ncbi.nlm.nih.gov/pubmed/35991754 http://dx.doi.org/10.1016/j.omto.2022.07.006

Ejemplares similares

Roles of Podoplanin in Malignant Progression of Tumor
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

Podoplanin: An emerging cancer biomarker and therapeutic target
por: Krishnan, Harini, et al.
Publicado: (2018)

A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin
por: Kato, Yukinari, et al.
Publicado: (2014)

Immunohistochemical Examination of Novel Rat Monoclonal Antibodies against Mouse and Human Podoplanin
por: Kaji, Chiaki, et al.
Publicado: (2012)

Characterization of Monoclonal Antibody LpMab-3 Recognizing Sialylated Glycopeptide of Podoplanin
por: Oki, Hiroharu, et al.
Publicado: (2015)

Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation
por: Yamada, Tomoharu, et al.
Publicado: (2020)

Epitope mapping of anti-mouse podoplanin monoclonal antibody PMab-1
por: Yamada, Shinji, et al.
Publicado: (2018)

Prediction of Tumor Development and Urine-Based Liquid Biopsy for Molecule-Targeted Therapy of Gliomas
por: Kurimoto, Michihiro, et al.
Publicado: (2023)

Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving tocilizumab: illustrative case
por: Ohno, Masasuke, et al.
Publicado: (2022)

A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma
por: Todo, Tomoki, et al.
Publicado: (2022)

Epitope Analysis of an Anti-Whale Podoplanin Monoclonal Antibody, PMab-237, Using Flow Cytometry
por: Sayama, Yusuke, et al.
Publicado: (2020)

Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial
por: Todo, Tomoki, et al.
Publicado: (2022)

Morphological study of tooth development in podoplanin-deficient mice
por: Takara, Kenyo, et al.
Publicado: (2017)

Development of an anti-bear podoplanin monoclonal antibody PMab-247 for immunohistochemical analysis
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma
por: Yajima, Shoh, et al.
Publicado: (2021)

An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas
por: Yamamichi, Akane, et al.
Publicado: (2016)

Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation
por: Sugawara, Kotaro, et al.
Publicado: (2021)

Expression of podoplanin in various types of feline tumor tissues
por: KAMOTO, Satoshi, et al.
Publicado: (2021)

Elucidation of Critical Epitope of Anti-Rat Podoplanin Monoclonal Antibody PMab-2
por: Furusawa, Yoshikazu, et al.
Publicado: (2018)

Establishment of a monoclonal antibody PMab-225 against alpaca podoplanin for immunohistochemical analyses
por: Kato, Yukinari, et al.
Publicado: (2019)

Neoadjuvant use of oncolytic herpes virus G47Δ prevents local recurrence after insufficient resection in tongue cancer models
por: Inoue, Kosuke, et al.
Publicado: (2023)

Oncolytic herpes virus G47Δ injected into tongue cancer swiftly traffics in lymphatics and suppresses metastasis
por: Uchihashi, Toshihiro, et al.
Publicado: (2021)

Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer
por: Sugawara, Kotaro, et al.
Publicado: (2020)

PMab-219: A monoclonal antibody for the immunohistochemical analysis of horse podoplanin
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

Therapeutic efficacy evaluation of radioimmunotherapy with (90)Y‐labeled anti‐podoplanin antibody NZ‐12 for mesothelioma
por: Sudo, Hitomi, et al.
Publicado: (2019)

Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma
por: Sudo, Hitomi, et al.
Publicado: (2021)

PMab-235: A monoclonal antibody for immunohistochemical analysis against goat podoplanin
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models
por: Suzuki, Hiroyuki, et al.
Publicado: (2023)

Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin
por: Kato, Yukinari, et al.
Publicado: (2018)

Determination of critical epitope of PcMab-47 against human podocalyxin
por: Itai, Shunsuke, et al.
Publicado: (2018)

The mouse–canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models
por: Kato, Yukinari, et al.
Publicado: (2018)

Oncolytic virus therapy: A new era of cancer treatment at dawn
por: Fukuhara, Hiroshi, et al.
Publicado: (2016)

Antitumor effect of novel anti‐podoplanin antibody NZ‐12 against malignant pleural mesothelioma in an orthotopic xenograft model
por: Abe, Shinji, et al.
Publicado: (2016)

Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma
por: Kamoto, Satoshi, et al.
Publicado: (2020)

Double-edged Sword in the Placement of Carmustine (BCNU) Wafers along the Eloquent Area: A Case Report
por: Kuramitsu, Shunichiro, et al.
Publicado: (2014)

Podoplanin promotes cell proliferation, survival, and migration of canine non-tonsillar squamous cell carcinoma
por: SHINADA, Masahiro, et al.
Publicado: (2023)

LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer
por: Miyazaki, Akihiro, et al.
Publicado: (2018)

A Real-Time Near-Infrared Fluorescence Imaging Method for the Detection of Oral Cancers in Mice Using an Indocyanine Green–Labeled Podoplanin Antibody
por: Ito, Akihiro, et al.
Publicado: (2018)

Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer
por: Matsumura, Shuichi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cu18ccmhl33ctkl96joten17lj